EACS guidelines (2015): translations in 11 languages now available online
1 June 2015. Related: Guidelines.
2015
Recommendations for management of bone health in people living with HIV
1 June 2015. Related: Guidelines.
Timing of very early ART to limit early HIV-related mucosal dysfunction
1 June 2015. Related: Basic science and immunology.
Broad CD8 T cell responses are required to overcome dominance of CTL escape in the latent HIV reservoir
1 June 2015. Related: Basic science and immunology.
Broadly neutralising antibody suppresses HIV in clinical trial
1 June 2015. Related: Basic science and immunology.
New clinical trial for extensively drug resistant TB (XDR-TB)
1 June 2015. Related: TB coinfection.
MSF report and call to action: Promising new TB drugs are not reaching patients
1 June 2015. Related: TB coinfection.
Sofosbuvir access: new patent challenges to sofosbuvir
1 June 2015. Related: Treatment access, Hepatitis coinfection.
Methmephangee – ChemSex vs recreational drug use: a proposed definition for health workers
1 June 2015. Related: HIV prevention and transmission.
WHO statement for public disclosure of clinical trial results
1 June 2015. Related: Other news.
2015 Conference on Retroviruses and Opportunistic Infections (CROI), 23-26 February 2015, Seattle
24 March 2015. Related: Conference reports.
Pre-CROI meetings and workshops
24 March 2015. Related: Conference reports, Meeting report.
CROI webcasts online
24 March 2015. Related: Conference reports.
March/April 2015: Volume 16 Number 3/4
24 March 2015. Related: Editorial.
Pipeline ART: tenofovir alafenamide (TAF)
24 March 2015. Related: Conference reports, Antiretrovirals.
Pipeline ART: maturation inhibitors and an attachment inhibitor
24 March 2015. Related: Conference reports, Antiretrovirals.
No HIV transmissions between gay couples when viral load is undetectable: preliminary results from “Opposites Attract” study in Australia, Thailand and Brazil
24 March 2015. Related: Conference reports, HIV prevention and transmission.
PrEP reduced HIV risk by at least 86% in PROUD: no transmissions likely from people taking meds
24 March 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Q&A on the PROUD study and PrEP results from CROI
24 March 2015. Related: Conference reports.
“On demand” PrEP dosing in IPERGAY: 86% reduced risk of HIV, no transmissions with active drug use
24 March 2015. Related: Conference reports, HIV prevention and transmission.
Other HIV PrEP studies at CROI 2015: implementation of oral PrEP and problems with tenofovir gel
24 March 2015. Related: Conference reports, HIV prevention and transmission.
Early HIV treatment and isoniazid prophylaxis: why TEMPRANO results do not yet support universal ART at CD4 counts >500
24 March 2015. Related: Conference reports, Treatment strategies, TB coinfection.
Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART
24 March 2015. Related: Conference reports, Women's health, PK and drug interactions.
Three drug ART best for preventing vertical transmission to infants: results from the PROMISE study
24 March 2015. Related: Conference reports, Pregnancy.
3 in 5 breastfeeding women with viral load >1,000 copies/mL are undiagnosed in Kenya, Malawi and South Africa
24 March 2015. Related: Conference reports, Pregnancy.
Point of care HIV PCR test for infant diagnosis: good performance but poorer results in youngest age group
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Diagnostics.
Weekend-off ART is non-inferior to continuous ART in young people taking efavirenz-based regimens: results from BREATHER study
24 March 2015. Related: Conference reports, Treatment strategies, Paediatric care.
Increased cardiovascular risks in HIV positive children in Uganda and Zambia partially reversed by ART
24 March 2015. Related: Conference reports, Paediatric care, Coinfections and complications.
Lopinavir/ritonavir superior to nevirapine in children <3 years old: IMPAACT P1060 five year results
24 March 2015. Related: Conference reports, Paediatric care.
Long-term safety and efficacy of tenofovir in children
24 March 2015. Related: Conference reports, Paediatric care.
UK case of HIV remission: ten years off-ART in patient with prior progression and treated during seroconversion
24 March 2015. Related: Conference reports, Cure-related research.
XXIV International HIV Drug Resistance Workshop , 21-22 February 2015, Seattle, Washington
24 March 2015. Related: Conference reports, Drug resistance.
Prevalence of transmitted drug resistance globally: highest in Australia, US and some European countries but between-country differences in all regions
24 March 2015. Related: Conference reports, Drug resistance.
Higher rates of K65R in non-B subtype in large UK cohort and implications of tenofovir resistance in resource-limited settings
24 March 2015. Related: Conference reports, Drug resistance.
Drug resistance and integrase inhibitors: potential impact of HIV subtype
24 March 2015. Related: Conference reports, Drug resistance.
Drug resistance in children after PMTCT and early treatment
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Drug resistance.
FDA approves fixed dose darunavir/cobicistat
24 March 2015. Related: Antiretrovirals.
FDA approves fixed dose atazanavir/cobicistat
24 March 2015. Related: Antiretrovirals.
FDA approves fixed dose raltegravir/3TC formulation: Merck holds back from marketing in US
24 March 2015. Related: Antiretrovirals.
Recommendations for management of bone disease in HIV
24 March 2015. Related: Coinfections and complications.
FDA approves 9-valent HPV vaccine: active against types 6, 11, 16, 18, 31, 33, 45, 52 and 58
24 March 2015. Related: Coinfections and complications.
NHS further delays access to sofosbuvir
24 March 2015. Related: Other news.
Public Health England outline plans to promote the health and wellbeing of gay and bisexual men
24 March 2015. Related: Other news.
START study video
24 March 2015. Related: On the web.
Diabetes in people with HIV: special issue of RITA
24 March 2015. Related: On the web.
NAT report: Young MSM in the UK
24 March 2015. Related: On the web.
Guidance on reporting results of clinical trials
24 March 2015. Related: On the web.
March/April 2015: Volume 16 Number 3/4
24 March 2015. Related: PDFs.
Five Nations Conference on HIV and Hepatitis – 8-9 December 2014, London
29 January 2015. Related: Conference reports.
Summary of the pre-conference clinical course
29 January 2015. Related: Conference reports, Hepatitis coinfection.
Hepatitis C drug access: Europe is the new Africa
29 January 2015. Related: Conference reports, Treatment access, Hepatitis coinfection.
January/February 2015: Volume 16 Number 1/2
29 January 2015. Related: PDFs.
45th Union World Conference on Lung Health, 28 October – 1 November 2014, Barcelona, Spain
29 January 2015. Related: Conference reports.
Good outcomes within the National Bedaquiline Clinical Access programme in South Africa
29 January 2015. Related: Conference reports, TB coinfection.
Pharmacokinetics and safety of moxifloxacin in children
29 January 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
TB in the ARROW trial of children on ART
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
Problems giving current second line TB drugs to children
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
Morocco’s acceptance of EU patent law threatens millions of lives
29 January 2015. Related: Treatment access.
Global Fund releases end-2104 numbers
29 January 2015. Related: Treatment access.
Dolutegravir and Truimeq approved in England
29 January 2015. Related: Antiretrovirals.
London prescribing guidelines updated to include dolutegravir and Triumeq
29 January 2015. Related: Antiretrovirals.
Adequate cerebrospinal fluid exposure of efavirenz when dosed at 400 mg
29 January 2015. Related: Antiretrovirals.
Three drug regimen superior for preventing vertical transmission in the PROMISE study
29 January 2015. Related: Pregnancy.
CMV associated with 50% increased risk of non-AIDS related mortality in HIV positive people
29 January 2015. Related: Side effects, Coinfections and complications.
Impact of smoking on life expectancy in HIV infection
29 January 2015. Related: Side effects, Coinfections and complications.